Metformin can be safely used in patients exposed to contrast media: a systematic review and meta-analysis

Conclusion: Metformin can be safely applied in patients with moderate renal impairment as low as eGFR ≥30 ml/min/1.73 m2 during the exposure of the CM.
Source: Cardiology - Category: Cardiology Source Type: research